Michael Varney, Frazier

Months af­ter re­tir­ing from Genen­tech, Michael Var­ney brings his drug hunt­ing eye to Fra­zier

Michael Var­ney be­gan his post-Genen­tech ca­reer by tak­ing a job as chair­man of R&D at a biotech start­up. Now he’s signed on for a new gig that will put him in di­rect con­tact with a whole lot more.

The biotech vet — who en­joyed a stel­lar rep­u­ta­tion run­ning Roche’s pres­ti­gious gRED or­ga­ni­za­tion in South San Fran­cis­co — is one of two fresh­ly mint­ed life sci­ences se­nior ad­vi­sors at Fra­zier Health­care Part­ners. Pfiz­er vet Don Frail has been tapped for the same role af­ter most re­cent­ly lead­ing the ex­ter­nal sci­ence and in­no­va­tion team at Al­ler­gan.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.